Vice President, Marketing - Neuroimmunology
Annexon Biosciences
Summary
We are seeking an accomplished Vice President, Marketing, Neuroimmunology to lead the commercial strategy and marketing execution for our Neuroimmunology portfolio. This individual will be a critical member of the Commercial Leadership Team, responsible for translating differentiated science and meaningful patient benefits into a compelling commercial strategy and exceptional launch execution.
Job description
Commercial & Brand Strategy
- Own the integrated commercial and marketing strategy for the neuroimmunology portfolio, from pre-launch through commercialization and lifecycle management.
- Develop differentiated positioning, value proposition, messaging, segmentation, targeting, and customer engagement strategies grounded in patient and HCP insights.
- Translate clinical evidence, disease burden, treatment pathways, and competitive dynamics into a clear and compelling commercial narrative.
- Identify the critical adoption drivers and barriers and develop strategies to accelerate appropriate utilization.
Launch Leadership
- Serve as a senior leader for launch strategy and operational readiness, establishing clear milestones, KPIs, decision points, and organizational priorities.
- Build and execute the launch plan across HCP marketing, field execution, digital and omnichannel engagement, congresses, peer-to-peer education, advocacy, and market development.
- Ensure tight integration across Marketing, Sales, Market Access, Medical Affairs, Patient Services, Supply/Trade, and Analytics.
- Develop launch scenarios and rapidly adapt strategy based on market insights, customer feedback, competitive developments, and early performance.
HCP & Customer Engagement
- Develop a deep understanding of the neuroimmunology treatment ecosystem, including specialists, hospitals and health systems, pharmacists, multidisciplinary care teams, patients, and advocacy organizations.
- Build sophisticated customer journeys and engagement strategies for priority HCP and institutional segments.
- Lead advisory boards, market research, message testing, and other insight-generation activities.
- Partner with field leadership to translate strategy into clear, actionable execution at the account and territory level.
Market Development
- Lead disease education and market development strategies designed to improve recognition of disease burden, unmet need, appropriate diagnosis, treatment, and urgency of intervention.
- Identify opportunities to reshape treatment paradigms and establish a new standard of care.
- Partner closely with Medical Affairs and advocacy stakeholders while maintaining appropriate functional independence and compliance.
Insights, Analytics & Performance
- Establish the critical commercial KPIs and leading indicators required to assess launch readiness and post-launch performance.
- Use quantitative and qualitative insights to continuously optimize targeting, messaging, channel mix, and resource allocation.
- Partner with forecasting and analytics teams to inform patient-based forecasts, scenario planning, market assumptions, and investment decisions.
Leadership & Organizational Development
- Build and develop a high-performing marketing organization as the portfolio progresses toward commercialization.
- Lead agencies and external partners with strong strategic and financial discipline.
- Establish a culture of ownership, urgency, accountability, collaboration, and high-quality execution.
- Communicate commercial strategy and performance effectively to executive leadership and other senior stakeholders.
Requirements
- Bachelor's degree required
- MBA or other advanced degree preferred
- Approximately 15+ years of progressive biopharmaceutical commercial experience, including significant marketing leadership responsibility
- Demonstrated experience leading a successful specialty, rare disease, neurology, immunology, or hospital-based product launch
- Strong experience across upstream and downstream marketing, including positioning, segmentation, targeting, market research, HCP strategy, omnichannel execution, and launch planning
- Experience working effectively in highly cross-functional environments involving Medical Affairs, Market Access, Sales, Regulatory, Legal, Finance, Analytics, and Operations
- Strong executive communication and influencing capabilities
- Track record of building teams and developing high-performing talent
- Direct experience in neurology, neuroimmunology, immunology, rare disease, or acute hospital-based therapeutics preferred
- Experience commercializing products where site-of-care economics, formulary access, coding and reimbursement, and institutional adoption materially influence uptake preferred
- Experience establishing or disrupting a treatment paradigm preferred
- Experience working in a pre-commercial or rapidly scaling biotechnology organization preferred
Benefits
- Flexible work schedules
- Remote opportunities
- Shuttle service
- Equity participation
- Employee stock purchase plan
- Medical, Dental & Vision
- 401(k)
- Flexible spending plans
Company overview
Annexon Biosciences (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company pioneering a novel approach to treating serious neuroinflammatory diseases by targeting the classical complement pathway. The company's distinctive scientific strategy focuses on inhibiting C1q, the initiating molecule of the classical complement cascade, which when dysregulated can lead to tissue damage and loss in various autoimmune, neurodegenerative, and ophthalmic disorders. Annexon is developing a portfolio of first-in-class therapeutics designed to stop complement-driven inflammation before it starts, addressing unmet medical needs across three therapeutic areas: autoimmunity, neurodegeneration, and ophthalmology. With its lead programs targeting conditions like Guillain-Barré syndrome and geographic atrophy, Annexon employs a biomarker-driven development strategy to advance its pipeline through mid-to-late stage clinical trials. The company's mission is to deliver transformative treatments that enable patients with debilitating neuroinflammatory diseases to live their best lives.